Momentum Group (MTM) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
3 Jul, 2026Executive summary
Normalized headline earnings grew 15% year-on-year to ZAR 5.54 billion, with NHE per share up 20% to 414 cents, supported by share buybacks and strong contributions across all business units.
Africa segment delivered positive earnings year-to-date, with new business sales up 15% and single premiums also up 15% due to favorable equity markets.
ROE stands at 23.3%, exceeding the 20% target set for F2027 and remaining the highest in the industry.
Major milestone achieved with Momentum Health starting administration of the Bonitas scheme, increasing annual claims processed from ZAR 70 billion to ZAR 100 billion.
Cost discipline maintained, with direct expenses up only 1%, well below inflation, and cumulative annualised savings of ZAR 641 million.
Financial highlights
Normalized headline earnings reached ZAR 5.54 billion, up 15% year-on-year for the nine months.
Headline earnings per share increased 20% to 414 cents; recurring premiums up 7% to ZAR 3.3 billion; single premiums up 15% to ZAR 50.2 billion.
PVNBP up 15% to ZAR 66.9 billion; VNB declined 4% to ZAR 347 million, with margin contracting to 0.5%.
Financial earnings outperformed expectations by ZAR 411 million, driven by yields, credit spreads, and equity markets.
Cost optimization led to direct cost growth of just 1% and a 4% reduction in costs for the January-March quarter compared to last year.
Outlook and guidance
The group remains on track to meet its ZAR 6 billion earnings target for the year.
Management expects continued improvement in VNB margin and further cost containment, with next year’s cost growth budgeted at 2%.
Global and South African economic uncertainty persists, with muted consumer demand and inflationary pressures.
Diversified business model and disciplined capital management position the group to navigate headwinds.
Share buybacks may resume if surplus capital is available after reassessment of required high-quality liquid assets at year-end.
Latest events from Momentum Group
- Earnings rose to ZAR 1.76bn, but VNB margin fell to 0.7% amid lower annuity sales.MTM
Q1 20268 Jul 2026 - Strong ROE, digital transformation, and disciplined execution drive ongoing momentum.MTM
CMD 202610 Jun 2026 - Earnings up 8%, dividend up 29%, solvency strong, and health admin expands with Bonitas.MTM
Q2 202631 Mar 2026 - Targets ZAR 7bn earnings, 20% ROE, and advice-led, digital growth by 2027.MTM
Investor Update13 Feb 2026 - Digital transformation, cost optimisation, and growth drive strong performance and future targets.MTM
CMD 20253 Feb 2026 - Earnings up 27% to ZAR 4.4bn, record sales, digital growth, and ZAR 1bn buyback approved.MTM
Q4 20243 Feb 2026 - Earnings up 44% to ZAR 3.437bn, dividend up 42%, with strong capital and segment results.MTM
Q2 20253 Feb 2026 - Strong new business growth, improved claims ratios, and robust solvency position.MTM
Q3 202431 Jan 2026 - Earnings and new business growth strong, with improved VNB and robust capital position.MTM
Q1 202513 Jan 2026